|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,637.00 GBX | -1.15% |
|
+3.13% | -1.17% |
| 03:30pm | What Bundibugyo Ebola vaccines and treatments are under development | RE |
| 12:42pm | ASTRAZENECA : JP Morgan remains its Buy rating | ZD |
EPS & Dividend: AstraZeneca PLC
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 2.87 | 2.9 | 2.9 | 3.1 | 3.2 | 3.337 | 3.524 | 3.659 |
| Rate of return | 2.44% | 2.15% | 2.15% | 2.37% | 1.72% | 1.81% | 1.91% | 1.98% |
| EPS 2 | 0.08 | 2.11 | 3.81 | 4.5 | 6.54 | 7.914 | 9.101 | 10.51 |
| Distribution rate | 3,588% | 137% | 76.1% | 68.9% | 48.9% | 42.2% | 38.7% | 34.8% |
| Reference price 2 | 117.51 | 135.16 | 135.02 | 131.05 | 185.60 | 184.54 | 184.54 | 184.54 |
| Nbr of stocks (in thousands) | 1,549,159 | 1,549,528 | 1,549,926 | 1,550,317 | 1,550,726 | 1,550,996 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 06/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
Past dividends: AstraZeneca PLC
| 19/02/2026 | Ex-dividend date - 1.595 GBX | 05:00 |
| 07/08/2025 | Ex-dividend date - 0.767 GBX | 05:00 |
Upcoming Events: AstraZeneca PLC
| 27/07/2026 | Earnings release | Q2 2026 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 1.81% | 1.91% | 23.32x | 5.39x | 4.83x | |
| 0.59% | 0.66% | 33.62x | 20.07x | 12.22x | |
| 2.3% | 2.4% | 24.81x | 6.25x | 5.72x | |
| 3.08% | 3.24% | 27.31x | -812.02x | 6.66x | |
| 3.11% | 3.18% | 17.31x | 6.38x | 4.28x | |
| 2.8% | 2.9% | 53.32x | 6.07x | 4.96x | |
| 3.08% | 3.16% | 20.51x | 6.13x | 5.3x | |
| 4.17% | 4.01% | 12.03x | 5.27x | 4.53x | |
| 2.92% | 3.08% | 22.48x | 16.76x | 6.03x | |
| 2.53% | 2.59% | -45.84x | 8.7x | 5.54x | |
| Average | 2.64% | 2.71% | 18.89x | -73.10x | 6.01x | |
| Weighted average by Cap. | 2.17% | 2.26% | 24.91x | -76.91x | 7.29x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition